{
    "clinical_study": {
        "@rank": "4903", 
        "arm_group": {
            "arm_group_label": "mesenchymal stem cell", 
            "arm_group_type": "Experimental", 
            "description": "stem cells drived from iliac bone marrow with centrifuge and ficoll method then implant in collagenic  3-D scaffold with BMP-2 and put in non union site by surgical approach under general or spinal anesthesia as deemed appropriate by the anesthetist."
        }, 
        "brief_summary": {
            "textblock": "Because the rate of non union of long bone in lower extremities specially in tibia in this\n      two last decade due to malnutrition and smoking and other risk factors was increased, so\n      many patient in our country suffer from non union. On the other hand it seems that the use\n      of the mesenchymal stem cells can irritate the union rate. Also for better result we used\n      the mesenchymal stem cells with BMP2 in collagenic scaffold. The collagen has a\n      osteoconductive effect and BMP2 and stem cells has a osteoinductive effect therefore this\n      combination is useful in filling the gap in non union site and irritate the union rate.\n\n      Mesenchymal stem cell derived from iliac bone marrow after centrifuge with ficoll procedure.\n      Then the investigators will follow the patient with monthly radiography and evaluate the\n      callus volume and clinical union and any side effect of this treatment. Clinical union\n      consider to relief pain in non union site and be stable in examination."
        }, 
        "brief_title": "Evaluation the Treatment of Nonunion of Long Bone Fracture of Lower Extremities (Femur and Tibia) Using Mononuclear Stem Cells From the Iliac Wing Within a 3-D Tissue Engineered Scaffold", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Nonunion of Fracture", 
        "condition_browse": {
            "mesh_term": [
                "Fractures, Bone", 
                "Fractures, Ununited"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Every patient with non union in the site of long bone fracture\n\n          -  Age more than 18 and under 60 years old\n\n          -  Fracture having no radiological callus after 6 months and absence of any hypertrophic\n             bone reaction.\n\n          -  No infection in site of surgery\n\n          -  Be able and willing to participate in the study\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Evidence of malignancy\n\n          -  Pregnancy or breastfeeding\n\n          -  Patient positive by serology or PCR for HIV, hepatitis B or C infection the patient\n             with Accompanied fracture such as hip fracture that could not weight bearing"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "18", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01958502", 
            "org_study_id": "910359"
        }, 
        "intervention": {
            "arm_group_label": "mesenchymal stem cell", 
            "intervention_name": "surgical treatment of non union with mesenchymal stem cells with BMP2 within a 3-D tissue engineered scaffold", 
            "intervention_type": "Genetic"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "nonunion", 
            "mesenchymal stem cell", 
            "scaffold", 
            "BMP2", 
            "long bone"
        ], 
        "lastchanged_date": "October 8, 2013", 
        "location": {
            "contact": {
                "email": "peivandimt@mums.ac.ir", 
                "last_name": "mohammad taghi peivandi, MD", 
                "phone": "989153143691"
            }, 
            "contact_backup": {
                "email": "aminra61@gmail.com", 
                "last_name": "amin razi, MD", 
                "phone": "989153118713"
            }, 
            "facility": {
                "address": {
                    "city": "Mashhad", 
                    "country": "Iran, Islamic Republic of", 
                    "state": "Khorasan"
                }, 
                "name": "Emdai Kamyab Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "bibi fatemeh kalalinia, PHD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "hosein hoseinkhani, PHD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "sara amel farzad, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "peivandimt@mums.ac.ir", 
            "last_name": "mohammad taghi peivandi, MD", 
            "phone": "+989153143691"
        }, 
        "overall_contact_backup": {
            "email": "aminra61@gmail.com", 
            "last_name": "Amin razi, MD", 
            "phone": "+989153118713"
        }, 
        "overall_official": [
            {
                "affiliation": "Emdadi Kamyab Hospital", 
                "last_name": "mohammad taghi peivandi, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Emdadi Kamyab Hospital", 
                "last_name": "amin razi, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "patients receiving Mesenchymal Stem Cells within a 3-D tissue engineered scaffold that develop a partial or complete callus at 1, 2, 3, 4 ,5 and 6 months evaluate with standard X-rays", 
            "measure": "clinical and radiological union at 1 month to 6 months", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01958502"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Emdadi Kamyab Hospital", 
            "investigator_full_name": "mohammad taghi peivandi", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Safety of Mesenchymal Stem Cells injection in nonunion fractures. Follow-up for revealing any significant immediate or late adverse effects(infection,malignancy,local or systemic allergic reaction)", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "source": "Emdadi Kamyab Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "National Taiwan University of Science and Technology", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Emdadi Kamyab Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}